Literature DB >> 1940720

The use of low doses of ACTH in the investigation of adrenal function in man.

S Crowley1, P C Hindmarsh, P Holownia, J W Honour, C G Brook.   

Abstract

We have investigated the adrenal response, in eight healthy adult men, to low doses of ACTH(1-24) in order to define a dose which will elicit a response similar to that obtained with the short Synacthen test. The studies were performed at 14.00 h and blood samples were withdrawn at 5-min intervals after an i.v. bolus injection of ACTH(1-24). The sampling interval was crucial in determining the timing of the peak response. Using sampling times of 0, 10, 15, 20, 25 and 30 min ensured detection of 47 out of 48 peaks. A dose-dependent rise in plasma cortisol concentration was observed with bolus injections of ACTH(1-24) between 30 and 250 ng/1.73 m2 body surface area. Increasing the dose to 500 ng/1.73m2 (500 times less than that used in the short Synacthen test) elicited an increment of plasma cortisol concentration of 200 nmol/l or greater in all subjects. Pretreatment with dexamethasone (1 mg) did not alter the timing of the peak cortisol concentration but blunted the increase (pretreatment: median, 159 nmol/l; range 83-239; on dexamethasone; median 62 nmol/l; range 21-207; P = 0.04). These data suggest that a dose of ACTH(1-24) of 500 ng/1.73 m2 satisfies the criteria of the short Synacthen test and may provide a useful method of investigating adrenal function.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1940720     DOI: 10.1677/joe.0.1300475

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  22 in total

Review 1.  Clinical usefulness of the low dose ACTH test.

Authors:  L Patel; P E Clayton
Journal:  J Endocrinol Invest       Date:  1999-05       Impact factor: 4.256

2.  The role of the low dose ACTH test in the evaluation of central hypoadrenalism.

Authors:  B Ambrosi; L Barbetta
Journal:  J Endocrinol Invest       Date:  1999-06       Impact factor: 4.256

3.  Repetitive graded ACTH stimulation test for adrenal insufficiency.

Authors:  T S Huang; Y D Jiang
Journal:  J Endocrinol Invest       Date:  2000-03       Impact factor: 4.256

4.  Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate.

Authors:  A J Drake; R J Howells; J P H Shield; A Prendiville; P S Ward; E C Crowne
Journal:  BMJ       Date:  2002-05-04

Review 5.  Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis.

Authors:  Rami Jean Salib; Peter Hugo Howarth
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 6.  Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids.

Authors:  B J Lipworth; J R Seckl
Journal:  Thorax       Date:  1997-05       Impact factor: 9.139

7.  Total and free cortisol levels during 1 μg, 25 μg, and 250 μg cosyntropin stimulation tests compared to insulin tolerance test: results of a randomized, prospective, pilot study.

Authors:  Seenia Peechakara; James Bena; Nigel J Clarke; Michael J McPhaul; Richard E Reitz; Robert J Weil; Pablo Recinos; Laurence Kennedy; Amir H Hamrahian
Journal:  Endocrine       Date:  2017-07-20       Impact factor: 3.633

8.  Clinical factors associated with biochemical adrenal-cortisol insufficiency in hospitalized patients.

Authors:  Stephanie M Gwin; Annika K Khine; Anat Ben-Shlomo; James Mirocha; Ning-Ai Liu; Renee C Sheinin; Shlomo Melmed
Journal:  Am J Med       Date:  2014-03-13       Impact factor: 4.965

9.  A comparison of the adrenal cortical response to ACTH stimulation in Angora and non-Angora goats.

Authors:  C Jiménez Escobar; P K Basrur; C Gartley; R M Liptrap
Journal:  Vet Res Commun       Date:  1998-02       Impact factor: 2.459

10.  Gap junction-mediated cell-to-cell communication in bovine and human adrenal cells. A process whereby cells increase their responsiveness to physiological corticotropin concentrations.

Authors:  Y Munari-Silem; M C Lebrethon; I Morand; B Rousset; J M Saez
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.